Loading stock data…
VTRS
$15.04+0.10 (+0.67%)
Market ClosedLast close May 1
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Viatris Inc. in the Healthcare sector is trading at $15.04. The stock is currently near its 52-week high of $16.47, remaining 28.0% above its 200-day moving average. Technical signals show overbought RSI of 75 and bullish MACD crossover, explaining why VTRS maintains its current momentum and trend strength. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Overbought levels (RSI 75) — risk of consolidation or pullback
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$15.04
Potential Upside
5%
Whystock Fair Value$15.79
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus9 analysts
Buy
Mean target$15.72+4.5%
Range$12.00 – $20.00
Fundamentals
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$17.18B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.82
Div Yield
Strong income play. Yield provides a meaningful total return floor.
325.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-23.58%
Volume
Today's trading volume
7.36M
Recent News
Is It Too Late To Consider Viatris (VTRS) After Its Strong One Year Share Price Run
If you are wondering whether Viatris at around US$15.04 is still offering value after a strong run, this article walks through what the current price might be implying. The stock has posted returns of 3.1% over the past 7 days, 11.9% over 30 days, 20.7% year to date, 82.0% over 1 year, 85.5% over 3 years and 31.8% over 5 years. This naturally raises questions about how much upside or risk is now reflected in the share price. Recent attention on Viatris has been shaped by ongoing coverage of...
Is Viatris (VTRS) One of the Best Medical Stocks to Buy Under $30?
Viatris Inc. (NASDAQ:VTRS) is one of the 10 Best Medical Stocks to Buy Under $30. On March 23, Barclays increased its price target on Viatris Inc. (NASDAQ:VTRS) from $15 to $17 while keeping an Overweight rating on the stock. Barclays noted that the muted market response to the company’s Investor Day was not surprising because […]
Viatris (VTRS) Earnings Expected to Grow: Should You Buy?
Viatris (VTRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Viatris' Q1 2026 Earnings: What to Expect
Viatris is set to announce its first-quarter earnings next month, and Wall Street expects the company’s EPS to increase by a single digit.
Natera, UFP Technologies, Mettler-Toledo, and Viatris Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after the reopening of the Strait of Hormuz signaled a cooling of global logistics and energy costs.